Will They or Won’t They (Block the Abortion Pill)?

0
344
Will They or Won’t They (Block the Abortion Pill)?


The Host

Supreme Court justices may act at any second on entry to the abortion tablet mifepristone. Beyond reproductive well being, their ruling may carry vital implications for states’ rights and FDA independence and integrity. For now, although, observers are not sure what the courtroom will do — or what precisely prompted justices to once more delay their resolution this week.

At the Capitol, lawmakers grumbled, scoffed, and bickered this week as House Speaker Kevin McCarthy revealed the Republican proposal to chop authorities spending. The package deal can be dead-on-arrival within the Democratic-controlled Senate. But of word is the pushback from inside McCarthy’s personal caucus, with some hard-right conservatives urgent to go additional by demanding the repeal of the Inflation Reduction Act in alternate for elevating the debt ceiling.

And President Joe Biden pursued new efforts to grant authorized standing to younger immigrants residing within the nation illegally who had been introduced right here as youngsters, typically known as “Dreamers,” as his administration introduced a plan to grant them entry to government-funded well being protection.

This week’s panelists are Mary Agnes Carey of KFF Health News, Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico.

Among the takeaways from this week’s episode:

  • The Supreme Court prolonged its keep on the usage of mifepristone by Friday, giving justices longer to behave on a serious, sophisticated case with nationwide implications for reproductive well being. It is unclear what the courtroom will do, although there are a number of actions it may take — together with sending the case again to the decrease courts or once more extending the keep and shopping for justices much more time to return to settlement or pen dissents.
  • GenBioPro, which produces the generic model of mifepristone, sued the FDA on Wednesday, trying to protect entry to the drug. About two-thirds of the mifepristone at the moment used within the United States is generic.
  • In congressional information, House Speaker McCarthy launched what’s successfully Republicans’ opening supply within the combat over elevating the debt ceiling. The package deal contains GOP well being priorities that might not garner wanted help within the Senate, like work necessities for Medicaid and the clawback of unspent covid-19 pandemic funds.
  • While well being prices are excessive throughout authorities applications, Medicaid takes the massive hit within the Republican proposal to chop federal spending. Republicans have embraced work necessities for presidency help since at the least the Eighties, but in Arkansas — a state that carried out work guidelines for Medicaid — it has proved difficult to confirm that enrollees are assembly these necessities.
  • The Senate Finance Committee, which has jurisdiction over a lot of federal well being spending, revealed a package deal this week to sort out drug pricing. While the proposal is within the early phases, it seeks to include bipartisan measures touching pharmacy profit managers, insulin customers, and extra.
  • And on the protection entrance, the Biden administration introduced that immigrant children dropped at the United States who stay right here below the Deferred Action for Childhood Arrivals program will be capable of apply for Medicaid and Affordable Care Act protection. This eligibility enlargement comes as states put together to disenroll those that now not qualify for Medicaid as the general public well being emergency’s protection protections expire. Expect a combat from some states as they resist being compelled to cowl insurance coverage for people residing within the U.S. with out authorized permission.

Plus, for “extra credit,” the panelists counsel well being coverage tales they learn this week that they assume you must learn, too:

Mary Agnes Carey: The New York Times’ “A Beauty Treatment Promised to Zap Fat. For Some, It Brought Disfigurement,” by Anna Kodé

Joanne Kenen: The New York Times’ “My Transplanted Heart and I Will Die Soon,” by Amy Silverstein

Sandhya Raman: ABC News’ “Puerto Rico’s Water Supply Is Being Depleted, Contaminated by Manufacturing Industry on the Island, Experts Say,” by Jessie DiMartino, Lilia Geho, and Julia Jacobo

Rachel Cohrs: The Wall Street Journal’s “‘I Hate You, Kathie Lee Gifford!’ Ozempic Users Report Bizarre Dreams,” by Peter Loftus


To hear all our podcasts, click on right here.

And subscribe to KFF Health News’ ‘What the Health? on SpotifyApple PodcastsStitcherPocket Casts, or wherever you take heed to podcasts.

LEAVE A REPLY

Please enter your comment!
Please enter your name here